Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06746766

Registry Study on Rare Cancers in Korea

This study aims to determine the participation rate of patients with registered rare cancers in clinical research.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Severance Hospital

Seoul, 03722, South Korea

Location status: Recruiting

About this study

Data collection includes:

  • Clinical characteristics (diagnosis, treatment information, primary/metastatic sites, staging, gender/age)
  • Survival information (diagnosis date, recurrence date, death date, disease progression)
  • Pathological information (diagnosis, genomic information)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged ≥19 years
  • Confirmed rare cancer
  • Life expectancy ≥3 months

Exclusion criteria

-Serious or unstable medical/psychiatric conditions

Treatment and study plan

Primary outcomes

  1. Establish a registry

    Time frame: 1 year

    Establish a registry of rare cancer patients visiting the institution

Secondary outcomes

  1. Clinical trial registration rate (%)

    Time frame: 1 year

    Clinical trial registration rate (%)

Study contacts

Contact information is provided by the study sponsor or research team.

Hyo Song Kim, MD, Ph.D

CONTACT

[email protected]

82-2-2228-8124

Sponsors and collaborators

Lead sponsor

Yonsei University

Other

Registry information

Acronym: rarecancer

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Dec 24, 2024
Registry last updated
Apr 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.